Page 570 - ePaper

and Innovation
(BIRTI).
BioPharmAlliance
cluster infrastructure
includes Research
centre of molecular and
structural biology,
Scale-up and pilot
facilities of chemical
and biotechnological
products, Development
centre of biological
products as well as
innovative enterprises.
7. Know-ledge Public &Multifunctio University of Latvia, Included Sketch 80 million 55 million Barriers:
The main foreseen
and the digital Private R&D nal cyclotron private investors – Intera activities/goal: in theproject for EUR + 250 EUR Insufficient funding
economy partnership centre in GmbH, Austria National cyclotron million
Salaspils and Revitalization of unit andEUR if Solutions:
Guidelin
Research
former
the Research es for the supporting proton Partially financing
Develop-
Platform of Nuclear reactor Medical therapy from EU funds and
territory in Salaspils
European ment of unit unit is attraction .of
relevance in and construction of 30 En- prepared, developed private investors for
Nanostructur MeV cyclotron facility vironmen reviataliza- commercialization
with
auxiliary
the
ed Materials, equipment for t tion of research.
the
High Energy Protectio concept
Radiation production of PET and n approved
isotopes,
SPECT
Techno- Measures by the
logies and radiopharmaceuticals, . Cabinet of
Innovation material research, Ministers,
liquid metal and nano
powder technologies. feasibility
studies
Supporting unit of started for
PET/CT/MRI medical individual
diagnostics and activities.
research, material
structure research,
service infrastructure
for international
researchers and users
of the facility.
Installation of semi–
industrial scale linear
electron accelerator.
Further perspective –
development of proton